Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Johnson, MB, ChB
Neurotech Pharmaceuticals, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Soroka Medical Center
Beersheba, Israel
- Hadassah-Hebrew University Medical Center
Jerusalem, Israel
- Meir Medical Center
Kfar Saba, Israel
- Rabin Medical Center
Petah Tikva, Israel
- Kaplan Medical Center
Rehovot, Israel
- Sourasky Medical Center,
Tel Aviv, Israel
- Associated Retina Consultants, Ltd.
Phoenix, Arizona, United States
- Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
- University of California, Irvine, the Gavin Herbert Eye Institute
Irvine, California, United States
- Jacobs Retina Center at Ucsd
La Jolla, California, United States
- Colorado Retina Associates
Golden, Colorado, United States
- National Ophthalmic Research Institute
Fort Myers, Florida, United States
- Retina Health Center
Fort Myers, Florida, United States
- Center for Retina and Macular Disease
Winter Haven, Florida, United States
- Southeast Retina Center, Pc
Augusta, Georgia, United States
- Georgina Retina, P.C.
Marietta, Georgia, United States
- Illinois Retina Associates, S.C.
Joliet, Illinois, United States
- Illinois Retina Associates
Oak Park, Illinois, United States
- Retina Associates of Kentucky
Lexington, Kentucky, United States
- the Retina Group of Washington
Chevy Chase, Maryland, United States
- Cumberland Valley Retina Consultants, Pc
Hagerstown, Maryland, United States
- Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
- University of Michigan, Kellogg Eye Center
Ann Arbor, Michigan, United States
- William Beaumont Hospital-Ophthalmology Research
Royal Oak, Michigan, United States
- Lifelong Vision Foundation
Chesterfield, Missouri, United States
- Sierra Eye Associates
Reno, Nevada, United States
- Retina Center of New Jersey, Llc
Bloomfield, New Jersey, United States
- Nj Retina
New Brunswick, New Jersey, United States
- Western Carolina Retinal Associates
Asheville, North Carolina, United States
- Wake Forest Baptist Health Eye Center
Winston-Salem, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Retina Northwest, Pc
Portland, Oregon, United States
- Mid Atlantic Retina
Philadelphia, Pennsylvania, United States
- Palmetto Retina Center, Llc
Florence, South Carolina, United States
- Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
- Valley Retina Institute, Pa
McAllen, Texas, United States
- Medical Center Ophthalmology Associates
San Antonio, Texas, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2014
- Primary completion
- 30 Apr 2016
- Completion
- 30 Apr 2016
- Last update posted
- 18 Jul 2022
- Registered enrollment
- 42
- Registry id
- NCT02228304
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.